The cytokine patterns we observe, specifically the increased levels of IL-1β, IL-6, and IL-8, indicate that additional therapies targeting proinflammatory pathways may be beneficial in reducing symptoms and preventing recurring infections. The gene discussed is IL1B; the disease is infection.